Vascular Access Devices - Company Evaluation Report, 2024 (Abridged Report)

The Vascular Access Devices Market Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Vascular Access Devices market . This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 25 Vascular Access Devices market Companies were categorized and recognized as the quadrant leaders.

A vascular access device (VAD) is a medical instrument inserted into a vein or artery to provide direct access to the bloodstream for delivering medications, fluids, or nutrients, as well as for drawing blood. Commonly used in long-term treatments like chemotherapy or dialysis, VADs are classified as central or peripheral depending on the site and duration of use. These devices are typically placed in the arm, chest, or leg and can remain in place for extended periods to support ongoing medical care.

The vascular access devices market is expected to grow from USD 5,991.2 million in 2024 to USD 9,057.2 million by 2030, at a CAGR of 7.1%. This growth is primarily driven by increased investment from key industry players and a rising prevalence of conditions that require vascular access. However, a shortage of skilled healthcare professionals may pose a challenge to market expansion.

The 360 Quadrant maps the Vascular Access Devices market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Vascular Access Devices market quadrant. The top criteria for product footprint evaluation included Type (central venous access devices, peripheral vascular access devices, accessories, intraosseous vascular access devices), By Route of Insertion (intravenous route of insertion, subcutaneous route of insertion, intraosseous route of insertion) By Application (drug administration, fluid & nutrition administration, blood transfusion, diagnostics & testing) By End User (hospitals, clinics & ambulatory care centers, other end users).

Key Players:

Key market players, such Beckton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical (US), Terumo Corporation (Japan), and B Braun SE (Germany), Medtronic (Ireland), Vygon (France), Amecath (Egypt), AngioDynamics (US), Medical Components, Inc. (US), and Nipro (Japan), Merit Medical Systems (US), Health Line International Corporation (US), Medi-Tech Devices Pvt. Ltd. (India), Cook (US), and Argon Medical Devices (US), Access Vascular, Inc. (US), PakuMedmedical Products GmbH (Germany), Guangdong Baihe Medical Technology Co., Ltd. (China), Shanghai Puyi Medical Instruments Co., Ltd. (China), Newtech Medical Devices Pvt. Ltd. (India), DeltaMed (Italy), Kimal (UK), PolyMedicure (India), and PFM Medical GmbH (Germany)

Becton Dickinson and Company (US)

Becton Dickinson, a key player in the vascular access devices market, is renowned for its robust geographic presence and extensive product portfolio that includes central and peripheral venous access catheters. The company's acquisition of C.R. Bard for USD 24 billion significantly enhanced its product portfolio and market share. BD's strong global distribution network supports market stability by mitigating demand fluctuations across various geographies.

Teleflex Incorporated (US)

Teleflex boasts a rich history and extensive experience in the vascular access devices sector. The company markets its products under the Arrow brand and continues to innovate by launching new products, such as the Arrow Pressure Injectable Midline Catheter. These strategic launches have strengthened Teleflex's market position by addressing clinician needs and enhancing patient safety. Teleflex's expansion into regions like Europe and Africa has further solidified its market position.

ICU Medical (US)

ICU Medical's competitive edge lies in its comprehensive product portfolio, featuring central venous catheters, needle-free connectors, and more. The company's 2022 acquisition of Smiths Medical broadened its capabilities in infusion therapy applications, thereby enhancing its global reach and strengthening its market presence. ICU Medical emphasizes high-quality products that meet rigorous regulatory standards, alongside offering training and support to healthcare professionals.